Results 271 to 280 of about 10,357,485 (302)

Vascular Endothelial Growth Factor (VEGF) Receptors

1995
Abstract Two tyrosine kinases have been recently identified as putative VEGF receptors (deVries et al. 1992; Terman et al. 1992a). The flt-1 (fms-like-tyrosine kinase; Shibuya et al. 1990) and KOR (kinase domain region; Terman et al. 1991) proteins have been shown to bind VEGF with high affinity.
J E Park, N Ferrara
openaire   +1 more source

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Expression in the Chick Embryo Area Vasculosa

The Histochemical Journal, 2001
Vascular endothelial growth factor is an angiogenic factor in vivo and in vitro that plays a crucial role in the control of blood vessel development and in pathological angiogenesis. The vascularized extraembryonic membranes of the chick embryo include the area vasculosa and the chorioallantoic membrane. In this study, we investigated the expression of
NICO, Beatrice, VACCA, Angelo, DE GIORGIS M, RONCALI L, RIBATTI, Domenico   +4 more
openaire   +2 more sources

Vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and cyclooxygenase-2 expression in psoriasis.

Analytical and quantitative cytology and histology, 2007
To investigate expression patterns and relationship of vascular endothelial growth factor (VEGF), vascular endothelial receptor-3 (VEGF-R3) (FLT-4) and cyclooxygenase-2 (COX-2) in psoriasis.Forty-three patients were included in this study. The clinical severity of psoriasis was assessed using the psoriasis area and severity index (PASI).
ERMAN, MUSTAFA, Tezel, Gaye Guler, ALLI, NURAN, ARDA, Nilüfer, YALÇIN, BAŞAK   +4 more
openaire   +2 more sources

Systemic Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Stage and Metastatic Breast Cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Özge Gümüşay, Laura A Huppert   +2 more
exaly  

Inhibitors of Vascular Endothelial Growth Factor Receptor

2017
Angiogenesis-targeting agents, predominantly inhibitors of vascular endothelial growth factor and its receptors, have become a mainstay in oncology practice over the last decade. The approved drugs, which include two antibodies and seven small molecule inhibitors, represent strong validation for the field of anti-angiogenesis in the treatment of cancer.
openaire   +1 more source

A receptor for vascular endothelial growth factor that stimulates endothelial apoptosis.

Cancer research, 2002
Vascular endothelial growth factor (VEGF) is a dimeric angiogenic factor that is overexpressed by many tumors and stimulates tumor angiogenesis. VEGF initiates signaling by dimerizing the receptors VEGFR-1 and VEGFR-2. The Fas receptor stimulates apoptosis, and artificial dimerization of the Fas cytoplasmic domain has been shown to induce apoptosis. We
T P, Quinn, S J, Soifer, K, Ramer, L T, Williams, M C, Nakamura   +4 more
openaire   +1 more source

Vascular Endothelial Growth Factors and Receptors

2010
Anna Dimberg, Charlotte Rolny, Laurens A. van Meeteren, Lena Claesson-Welsh   +3 more
openaire   +1 more source

Treatment of Renal Cell Carcinoma: Current Status and Future Directions

Ca-A Cancer Journal for Clinicians, 2017
Brian Rini, Pedro Coelho Barata
exaly  

Vascular-endothelial-growth-factor-receptor-antagonists

Reactions Weekly, 2022
openaire   +1 more source

Mutation in Vascular Endothelial Growth Factor-C, a Ligand for Vascular Endothelial Growth Factor Receptor-3, Is Associated With Autosomal Dominant Milroy-Like Primary Lymphedema

Circulation Research, 2013
Sahar Mansour, Pia Ostergaard, Andreas van Impel   +2 more
exaly